No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MEG240719C22500
- 19.21
- 0.000.00%
15min DelayClose Apr 18 13:32 ET
0.00High0.00Low
0.00Open19.21Pre Close0 Volume0 Open Interest22.50Strike Price0.00Turnover4571.23%IV34.16%PremiumJul 19, 2024Expiry Date8.59Intrinsic Value100Multiplier-4DDays to Expiry10.62Extrinsic Value100Contract SizeAmericanOptions Type0.8683Delta0.0135Gamma1.62Leverage Ratio-44.9705Theta0.0000Rho1.40Eff Leverage0.0007Vega
Intraday
- 5D
- Daily
News
Sector Update: Energy Stocks Retreat in Late Tuesday Afternoon Trading
Montrose Environmental Group, Inc.'s (NYSE:MEG) 28% Share Price Plunge Could Signal Some Risk
Montrose Environmental to Provide Fluoroalkyl Treatment at Waste Connections Landfill in Missouri
Montrose Environmental Group Announces Timing of Second Quarter 2024 Results
Montrose Environmental Group Partners With Waste Connections to Use Patented PFAS Treatment System to Address PFAS-Impacted Landfill Leachate
Favourable Signals For Montrose Environmental Group: Numerous Insiders Acquired Stock
Comments
The insider purchases suggest that the insiders consider the stock undervalued at lower prices. However, these transactions don't provide much insight into what they think of current prices. The level of insider ownership suggests alignment between insiders and other shareholders.
Favourable Signals For Montrose Environmental Group: Numerous Insiders Acquired Stock 1
Montrose Environmental Group's acquisition of Epic Environmental is set to boost its growth in Australia, expanding its capabilities, relationships, and services. The merger is expected to create a more comprehensive environmental solutions platform in Australia.
Montrose Environmental Group, trading at intrinsic value of $22.48, factors in optimistic future outlook. High share price volatility may offer future buying opportunity. Consider balance sheet strength and other factors for potential investment.
Gainers:
• $MorphoSys(MOR.US$ +7.9% (entered into equity participation and license agreements for felzartamab and MOR210)
• $Day One Biopharmaceuticals(DAWN.US$ +7.4% (prices offering of 10 mln shares of common stock at $15.00 per share)
• $Hertz Global(HTZ.US$ +6.1% (authorizes new $2.0 bln share repurchase program)
• $EverCommerce(EVCM.US$ +3.6% (announces $50 million share repurchase program)
• $Sprinklr(CXM.US$ +3.6% (In ...
• $MorphoSys(MOR.US$ +7.9% (entered into equity participation and license agreements for felzartamab and MOR210)
• $Day One Biopharmaceuticals(DAWN.US$ +7.4% (prices offering of 10 mln shares of common stock at $15.00 per share)
• $Hertz Global(HTZ.US$ +6.1% (authorizes new $2.0 bln share repurchase program)
• $EverCommerce(EVCM.US$ +3.6% (announces $50 million share repurchase program)
• $Sprinklr(CXM.US$ +3.6% (In ...
13
Upgrades
• $Albemarle(ALB.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $285 (from $215)
• $Alcon(ALC.US$ : Stephens Upgrades to Overweight from EqualWeight - PT $92 (from $86)
• $Atlantica Sustainable Infrastructure(AY.US$ : BofA Securities Upgrades to Buy from Neutral - PT $33 (from $38)
• $Coupang(CPNG.US$ : Citigroup Upgrades to Buy from Neutral - PT $15 (from $29)
• $89bio(ETNB.US$ : Raymond James Upgrades to Strong Buy from Outp...
• $Albemarle(ALB.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $285 (from $215)
• $Alcon(ALC.US$ : Stephens Upgrades to Overweight from EqualWeight - PT $92 (from $86)
• $Atlantica Sustainable Infrastructure(AY.US$ : BofA Securities Upgrades to Buy from Neutral - PT $33 (from $38)
• $Coupang(CPNG.US$ : Citigroup Upgrades to Buy from Neutral - PT $15 (from $29)
• $89bio(ETNB.US$ : Raymond James Upgrades to Strong Buy from Outp...
16
1
Read more